Oral leukoplakias: to treat or not? [Oral Oncol. 1997] - PubMed

loading

Review [Chemoprevention of oral cancer]. [Tidsskr Nor Laegeforen. 2003]
Review [Chemoprevention of oral cancer].
Sudbø J. Tidsskr Nor Laegeforen. 2003 May 29; 123(11):1518-21.
Review Oral leukoplakia: a proposal for uniform reporting. [Oral Oncol. 2002]
Review Oral leukoplakia: a proposal for uniform reporting.
van der Waal I, Axéll T. Oral Oncol. 2002 Sep; 38(6):521-6.
Three-year follow-up of oral leukoplakia after neodymium:yttrium aluminum garnet (Nd:YAG) laser surgery. [Lasers Med Sci. 2008]
Three-year follow-up of oral leukoplakia after neodymium:yttrium aluminum garnet (Nd:YAG) laser surgery.
Vivek V, Jayasree RS, Balan A, Sreelatha KT, Gupta AK. Lasers Med Sci. 2008 Oct; 23(4):375-9. Epub 2007 Oct 27.
Long-term treatment outcome of oral premalignant lesions. [Oral Oncol. 2006]
Long-term treatment outcome of oral premalignant lesions.
Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Oral Oncol. 2006 May; 42(5):461-74. Epub 2005 Nov 28.
Review Interventions for treating oral leukoplakia. [Cochrane Database Syst Rev. 2006]
Review Interventions for treating oral leukoplakia.
Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Cochrane Database Syst Rev. 2006 Oct 18; (4):CD001829. Epub 2006 Oct 18.

Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma. [Cancer. 2010]
Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma.
Ogbureke KU, Abdelsayed RA, Kushner H, Li L, Fisher LW. Cancer. 2010 Apr 1; 116(7):1709-17.
Oral premalignancy: new methods of detection and treatment. [Curr Oncol Rep. 2006]
Oral premalignancy: new methods of detection and treatment.
Gillenwater A, Papadimitrakopoulou V, Richards-Kortum R. Curr Oncol Rep. 2006 Mar; 8(2):146-54.
Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. [J Clin Pathol. 2002]
Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland.
Cruz I, Napier SS, van der Waal I, Snijders PJ, Walboomers JM, Lamey PJ, Cowan CG, Gregg TA, Maxwell P, Meijer CJ. J Clin Pathol. 2002 Feb; 55(2):98-104.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Oral leukoplakias: to treat or not?
Oral leukoplakias: to treat or not?
Oral Oncol. 1997 Sep ;33(5):317-21.

PubMed
Epidemiology and prevention of oral cancer.
Epidemiology and prevention of oral cancer.
Oral Oncol. 1997 Sep ;33(5):302-12.

PubMed
Beyond pleasure and pain.
Beyond pleasure and pain.
Am Psychol. 1997 Dec ;52(12):1280-300.

PubMed
Prolactin signal transduction mechanisms in the mammary gland: the role of the J...
Prolactin signal transduction mechanisms in the mammary gland: the role of the Jak/Stat pathway.
Rev Reprod. 1996 Jan ;1(1):1-5.

PubMed
A population-based study of seizures after traumatic brain injuries.
A population-based study of seizures after traumatic brain injuries.
N Engl J Med. 1998 Jan 1 ;338(1):20-4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed